Receptor Occupancy Fails to Predict Immune Activation in Pembrolizumab Dosing Study
A translational modelling study finds that PD-1 receptor occupancy does not predict immune activation during pembrolizumab therapy, challenging current dosing...
Nathaniel Bowman is a Scienmag editorial specialist profile for Precision Oncology coverage.
A translational modelling study finds that PD-1 receptor occupancy does not predict immune activation during pembrolizumab therapy, challenging current dosing...
A new commentary warns that the three-factor risk model proposed for esophageal cancer patients achieving pathological complete response after neoadjuvant...
New research shows that the blood lipid protein ApoA2 promotes metastasis and chemotherapy resistance in hepatocellular carcinoma by activating an...
A new survey of vestibular schwannoma patients finds widespread employment changes after treatment but only limited financial toxicity for most...
The largest dosimetry study of terbium-161 PSMA-617 radioligand therapy shows high tumor-absorbed doses with tolerable organ exposure in prostate cancer...
A national analysis of nearly 2,800 female breast cancer survivors shows that higher income sharply reduces cardiovascular disease risk, but...
A nationwide cohort study of over 635,000 South Korean cancer patients found that low muscle mass independently raised the risk...
A qualitative study of patients with advanced bladder and kidney cancer on immune checkpoint inhibitor therapy finds they want structured...
A comprehensive analysis of 136 registered clinical trials reveals that therapeutic vaccines for ovarian cancer have advanced steadily for three...
Bioactive compounds from the medicinal tree Pistacia integerrima suppress the growth and migration of lung cancer cells by targeting PI3K,...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine